Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zdenka, Gojkovic"'
Autor:
Milana Bosanac, Jelena Amidzic, Maja Stefanovic, Jelena Radic, Ivana Kolarov-Bjelobrk, Stefan Janicic, Zdenka Gojkovic, Bojana Lazic, Dejan Djokanovic, Aleksandra Misan, Biljana Cvetkovic, Alena Stupar, Nikola Martic, Bojana Andrejic-Visnjic
Publikováno v:
International Journal of Morphology. 41:231-236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db04d00f285398f133ea6aef946f6248
https://doi.org/10.4067/s0717-95022023000100231
https://doi.org/10.4067/s0717-95022023000100231
Autor:
Dejan Djokanovic, Bojana Lazic, Zdenka Gojkovic, Zeljka Cvijetic, Emir Sokolovic, Timur Ceric, Sasa Jungic
Publikováno v:
Srpski arhiv za celokupno lekarstvo. 151:209-215
Introduction/Objective. The purpose of this study was to assess the effectiveness of different approaches in the treatment of metastatic melanoma in daily clinical practice in a situation with limited and late availability of new drugs in a resource-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dff0615f10ae9ae1300b0e35329e1d5a
https://doi.org/10.2298/sarh220207006d
https://doi.org/10.2298/sarh220207006d
Autor:
Dejan Djokanovic, Zdenka Gojkovic, Sasa Jungic, Jelena Berendika, Radoslav Gajanin, Biljana Tubić, Ivanka Rakita, Milka Vjestica
Publikováno v:
Vojnosanitetski pregled. 79:796-804
Background/Aim. Standard treatment options for the first-line treatment of metastatic colorectal carcinoma (mCRC) are 5-fluorouracil, folinic acid, oxaliplatin (FOL-FOX4)/capecitabine (CapOx), plus bevacizumab (bev) and 5-fluorouracil, folinic acid a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::249d0f7340b0a608f581aeffe3a776e4
https://doi.org/10.2298/vsp200924053j
https://doi.org/10.2298/vsp200924053j
Autor:
Jelena Berendika, Gordan Nikic, Gordana Malčić Kecman, Božana Babić, Ivanka Rakita, Sasa Jungic, Biljana Tubić, Milka Vjestica, Zdenka Gojkovic
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 1, Pp 610-615 (2021)
Case Reports in Oncology, Vol 14, Iss 1, Pp 610-615 (2021)
Malignant salivary gland tumors form 11% of all head and neck tumors. Salivary duct carcinoma (SDC) of the parotid gland is an uncommon and highly aggressive tumor accounting for 2% of all salivary gland malignancies. The fourth edition of the WHO Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b195ca9e30697735fd265ea0552d46b7
http://europepmc.org/articles/PMC8077616
http://europepmc.org/articles/PMC8077616
Autor:
Nikolina Dukić, Sladjana Popovic, Nenad Lalovic, Srdjan Masic, Zdenka Gojkovic, Jelena Vladičić-Mašić
Publikováno v:
Archive of Oncology. 26:10-15
Background: Of all breast cancers 20-25% are HER2 positive. Overexpression of HER2 protein on the surface of the malignant cell leads to excessive cell proliferation through different signaling pathways. Trastuzumab is a human monoclonal antibody tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9816bb99d305e3e164cf27b06dfd518
https://doi.org/10.2298/aoo181112006d
https://doi.org/10.2298/aoo181112006d
Autor:
Danijela, Trokic, Goran, Marosevic, Vlado, Simeunovic, Stanislava, Lekic, Bozana, Babic, Zdenka, Gojkovic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(2)
The purpose of this study was to evaluate Ki67 as a biomarker for response to concurrent chemo-radiotherapy in previously treated patients with standard chemotherapy protocols in the neoadjuvant setting (NACT).Evaluated were 33 patients treated concu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48acedae282a4d5da7cba158fb433499
https://pubmed.ncbi.nlm.nih.gov/34076994
https://pubmed.ncbi.nlm.nih.gov/34076994
Autor:
Božana Babić, Milka Vjestica, Đokanović D, Savić S, Jelena Berendika, Zdenka Gojkovic, Gordan Nikic, Biljana Tubić, Sasa Jungic
Introduction: Mixed adenoneuroendocrine carcinoma (MANEC) is a tumor of the gastrointestinal tract that contains both exocrine and endocrine components, with each component representing a minimum of 30% of the total tumor mass.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dadf9e999c4576dda60ab1fbee5ca6d4
https://doi.org/10.22541/au.161531973.37978628/v1
https://doi.org/10.22541/au.161531973.37978628/v1
Publikováno v:
Biomedicinska istraživanja, Vol 9, Iss 1, Pp 8-15 (2018)
Introduction. There has been a progressive increase in the frequency of colorectal carcinoma for the last twenty years. In order for a doctor to estimate the life expectancy and/or the treatment of these patients, oncology makes use of prognostic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d4d77568631bab2f8debdcaa055b7d
http://www.biomedicinskaistrazivanja.com/wp-content/uploads/2018/07/02-Maksimovic-S.pdf
http://www.biomedicinskaistrazivanja.com/wp-content/uploads/2018/07/02-Maksimovic-S.pdf
Publikováno v:
Vojnosanitetski Pregled, Vol 74, Iss 3, Pp 249-255 (2017)
Background/Aim. The efficacy and safety of bevacizumab (BEV) in combination with capecitabin and irinotecan in first-line therapy for patients with metastatic colorectal cancer (mCRC) were studied. In order to improve safety and efficacy of chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7106ae008e6c435adeb0d9ecc95e6f06
http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600173J.pdf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600173J.pdf
Autor:
Sasa Jungic, Zdenka Gojkovic, Ivanka Rakita, Dejan Djokanovic, Tamara Visekruna, Gordan Nikic, Milka Vjestica, Olja Jovic-Djokanovic, Jelena Berendika, Zoran Mavija
Publikováno v:
Vojnosanitetski Pregled, Vol 77, Iss 11, Pp 1235-1236 (2020)
nema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f03fe0f7eba62ce093173d8d6b69705
https://doi.org/10.2298/vsp201016114g
https://doi.org/10.2298/vsp201016114g